FDA Approved: MONTELUKAST — Original Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves the original abbreviated new drug application for Montelukast (generic) submitted by XLCare Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Montelukast (Montelukast)
• Montelukast Sodium (Montelukast Sodium)

Snippet

ORIG AP for MONTELUKAST (MONTELUKAST)